Modified Release Tacrolimus in De Novo Immunosuppression After Simultaneous Pancreas–Kidney Transplantation—A First Single-Center Experience
Author:
Publisher
Elsevier BV
Subject
Transplantation,Surgery
Reference9 articles.
1. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004;Gruessner;Clin Transplant,2005
2. First clinical experience with the new once-daily formulation of tacrolimus;First;Ther Drug Monit,2008
3. Review of the clinical experience with a modified release form of tacrolimus [FK506E (MR4)] in transplantation;Wente;Clin Transplant,2006
4. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants;Didlake;Transplant Proc,1988
5. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation;Weng;J Am Soc Nephrol,2005
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08
2. Randomized open-label crossover assessment of Prograf vs Advagraf on immunosuppressant pharmacokinetics and pharmacodynamics in simultaneous pancreas-kidney patients;Clinical Transplantation;2018-01-29
3. Preparation of High-Payload, Prolonged-Release Biodegradable Poly(lactic-co-glycolic acid)-Based Tacrolimus Microspheres Using the Single-Jet Electrospray Method;Chemical and Pharmaceutical Bulletin;2016
4. Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug–drug interactions;Expert Opinion on Drug Metabolism & Toxicology;2014-09-26
5. Prevention of organ rejection in renal and liver transplantation with extended release tacrolimus;Transplant Research and Risk Management;2014-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3